Maria A. Lavanderos
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer.
Journal: Frontiers in oncology
Published: March 07, 2025
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Journal: Frontiers in pharmacology
Published: February 28, 2023
Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy.
Journal: Frontiers in pharmacology
Published: January 30, 2021
Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: April 02, 2020
High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis.
Journal: Scientific reports
Published: May 08, 2019
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
Journal: Frontiers in pharmacology
Published: December 28, 2018
Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
Journal: Current drug metabolism
Published: August 23, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026